Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma

S A Schey, P Fields, J B Bartlett, I A Clarke, G Ashan, R D Knight, M Streetly, A G Dalgleish

Research output: Contribution to journalArticlepeer-review

303 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences